Accelerate Diagnostics, Tucson, Arizona, USA
University of Arizona, Department of Pathology, Tucson, Arizona, USA.
J Clin Microbiol. 2019 Jun 25;57(7). doi: 10.1128/JCM.00353-19. Print 2019 Jul.
The Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing agree that carbapenemase testing is not necessary for clinical care, provided that the laboratory is up to date with current breakpoints. Nonetheless, publication on the development and modification of carbapenemase tests continues, as is the case in this issue of the (R. W. Beresford and M. Maley, J Clin Microbiol 57:e01852-18, 2019, https://doi.org/10.1128/JCM.01852-18). This commentary explores modifications to the carbapenem inactivation method-but is this the right focus for clinical laboratories?
临床和实验室标准协会和抗菌药物敏感性试验欧洲委员会同意,只要实验室使用的是最新的折点,那么进行碳青霉烯酶检测对于临床护理来说并非必要。然而,碳青霉烯酶检测方法的开发和修改仍在继续出版,正如本期的《临床微生物学杂志》(R. W. Beresford 和 M. Maley,J Clin Microbiol 57:e01852-18, 2019, https://doi.org/10.1128/JCM.01852-18)中所报道的。本评论探讨了碳青霉烯酶失活方法的修改,但这是否是临床实验室的正确关注点呢?